Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$767M |
| 2 |
MSCI
MSCI
|
+$677M |
| 3 |
Amazon
AMZN
|
+$629M |
| 4 |
Union Pacific
UNP
|
+$538M |
| 5 |
Meta Platforms (Facebook)
META
|
+$492M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$912M |
| 2 |
Tesla
TSLA
|
+$774M |
| 3 |
CSX Corp
CSX
|
+$767M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$689M |
| 5 |
PNC Financial Services
PNC
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.09% |
| 2 | Consumer Discretionary | 17.6% |
| 3 | Healthcare | 16.02% |
| 4 | Industrials | 14.5% |
| 5 | Technology | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
ATI
ATI
$28.2B
| $227M | 0.65% |
1,153,880
-2,178,963
| -65% | -$369M |
|
52
Roivant Sciences
ROIV
$26.2B
| $222M | 0.63% |
6,271,467
-380,981
| -6% | -$11.3M |
|
|
SPCX
53
SpaceX
SPCX
$1.81T
| $205M | 0.58% |
+1,200,000
| New | +$204M |
|
54
Amer Sports
AS
$19B
| $201M | 0.57% |
5,954,351
-1,316,125
| -18% | -$46.1M |
|
|
MANE
55
Veradermics Inc
MANE
$4.3B
| $192M | 0.55% |
1,561,494
-129,061
| -8% | -$12.1M |
|
|
MDLN
56
Medline Inc
MDLN
$30.1B
| $191M | 0.54% |
4,841,080
-6,592,912
| -58% | -$266M |
|
57
BCE
BCE
$22.1B
| $181M | 0.51% |
+8,383,278
| New | +$201M |
|
58
US Foods
USFD
$23.7B
| $177M | 0.51% |
+1,734,346
| New | +$155M |
|
|
ORKA
59
Oruka Therapeutics
ORKA
$7.15B
| $143M | 0.41% |
1,503,478
-1,163,212
| -44% | -$77.5M |
|
60
NewAmsterdam Pharma
NAMS
$3.33B
| $142M | 0.41% |
4,203,567
| – | – |
|
|
SION
61
Sionna Therapeutics
SION
$239M
| $141M | 0.4% |
3,195,181
| – | – |
|
62
Chubb
CB
$132B
| $129M | 0.37% |
377,312
-917,699
| -71% | -$299M |
|
63
Pharvaris
PHVS
$2.55B
| $126M | 0.36% |
3,653,310
| – | – |
|
64
UBS Group
UBS
$163B
| $121M | 0.34% |
+2,435,805
| New | +$111M |
|
65
BrightSpring Health Services
BTSG
$11.6B
| $113M | 0.32% |
+1,618,237
| New | +$89.9M |
|
66
Inhibrx
INBX
$1.53B
| $106M | 0.3% |
1,123,929
-313,776
| -22% | -$31.4M |
|
67
Natera
NTRA
$47.9B
| $106M | 0.3% |
+390,694
| New | +$83.3M |
|
68
Deutsche Bank
DB
$71.1B
| $85M | 0.24% |
+2,510,554
| New | +$81.4M |
|
69
Capital One
COF
$134B
| $77.8M | 0.22% |
387,815
-1,224,559
| -76% | -$234M |
|
70
Corebridge Financial
CRBG
$14.2B
| $76.7M | 0.22% |
+2,679,371
| New | +$72.5M |
|
71
SolarEdge
SEDG
$1.9B
| $63.6M | 0.18% |
+1,088,469
| New | +$57M |
|
|
DMRA
72
Damora Therapeutics
DMRA
$1.9B
| $60.1M | 0.17% |
2,311,082
| – | – |
|
73
Oric Pharmaceuticals
ORIC
$1.47B
| $55.5M | 0.16% |
5,126,762
-697,771
| -12% | -$6.33M |
|
74
Bruker
BRKR
$9.07B
| $53.8M | 0.15% |
+893,491
| New | +$41.7M |
|
75
Standard BioTools
LAB
$263M
| $48.3M | 0.14% |
58,651,170
| – | – |
|
Similar funds
Andreas Halvorsen's Q2 2026 Portfolio in Review
As of Q2 2026, Andreas Halvorsen held 111 positions worth $35.1B, down 1.9% from $35.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Andreas Halvorsen withdrew a net $3.53B in Q2 2026, closing 21 positions and reducing 28 holdings. Its most notable exit was Apple, an estimated $912M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Andreas Halvorsen opened a new position in Ferrari worth $817M.
- Andreas Halvorsen's largest Q2 2026 buy was Ferrari: 2,204,309 shares worth $817M.
- Andreas Halvorsen added most to Amazon in Q2 2026, an estimated $629M increase.
- Andreas Halvorsen's biggest Q2 2026 reduction was Tesla, cutting an estimated $774M.
- Andreas Halvorsen fully exited Apple in Q2 2026, selling an estimated $912M.
- Andreas Halvorsen's ten largest holdings make up 36% of its $35.1B portfolio in Q2 2026.
- Andreas Halvorsen opened 34 new positions and closed 21 in Q2 2026.
- Andreas Halvorsen's portfolio value fell 1.9% quarter-over-quarter to $35.1B.
Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.